1-U

CURRENT REPORT PURSUANT TO REGULATION A

Company: 20/20 Biolabs, Inc.
Filed: April 6, 2020
Period of Report: April 6, 2020
Accession Number: 0001213900-20-008668

View Document ↗ View on SEC.gov ↗